In this video, I will go over Novo Nordisk's (NVO-3.62%) and Eli Lilly's recent earnings report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been completed, after months of debate over potential antitrust issues.

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...

Biosynthesis can be exploited for chemical synthesis in vitro or in cells like Escherichia coli by combining substrates with enzymes using recombinant methods. Medium- and branched-chain diols and ...

Pork has moderately high amounts of purines—compounds that produce uric acid when digested. If you have gout, it is important to maintain a low-purine diet. Pork can be part of a healthy gout diet if ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

After hours: 7:59:01 p.m. EST ...

We introduce Sana, a text-to-image framework that can efficiently generate images up to 4096 × 4096 resolution. Sana can synthesize high-resolution, high-quality images with strong text-image ...